ERBB2 and neoplasm: utilized these methods to obtain gene expression-based cellular signatures that were used to classify BC cells into five intrinsic molecular subtypes: basal-like, normal-like, HER2-enriched, luminal A and luminal B. Notably, this classification scheme aligned with tumor subtype differences related to tumor cell origin and differential progression characteristics.